EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Dexmedetomidine as an Adjunctive Sedative in Patients Undergoing Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis

Hazem Abosheaishaa, Abdallfatah Abdallfatah, Abdelmalek Abdelghany, Arshia Sethi, Abdellatif Ismail, Doha Mohamed, Moataz Aboeldahb, Omar Abdelhalim, Islam Mohamed, Ahmed Y Azzam, Muhammed Amir Essibayi, David J Altschul und 2 weitere

ASIDE Gastroenterology · 2025

DOI: 10.71079/aside.gi.0109257 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift ASIDE Gastroenterology, 2025. Verfasst von Hazem Abosheaishaa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Icahn School of Medicine at Mount Sinai / NYC Health + Hospitals Queens, NY, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Endoscopic submucosal dissection (ESD) is a technique for removing dysplastic lesions in the gastrointestinal tract, but it carries risks like pain and perforation. Dexmedetomidine, an α2-receptor agonist, offers potential benefits as an adjunct sedative during ESD by providing anxiolysis and analgesia. This systematic review and meta-analysis assess its efficacy and safety. Methodology: We searched databases including Embase, Medline/PubMed, Scopus, and Web of Science up to April 21, 2024, following PRISMA guidelines. Eligible studies used dexmedetomidine with other sedatives for ESD. We analyzed outcomes such as en-bloc and complete resection rates, sedation duration, and adverse events, using RevMan for meta-analysis with a random-effects model.

Results

The initial search retrieved 216 studies, and eight studies were included in the final analysis after screening. Dexmedetomidine showed no significant difference in en-bloc or complete resection rates compared to controls. Sedation and procedure times were similar between the two groups as well. Dexmedetomidine significantly reduced restlessness (OR 0.15, 95% CI:0.07 to 0.29) and increased bradycardia (OR 7.15, 95% CI 3.17 to 16.11) compared to controls. Upon subgroup analysis, Dexmedetomidine plus Propofol and Dexmedetomidine plus Midazolam revealed the same findings regarding restlessness and bradycardia compared to controls, which confirmed the adjunctive effects of Dexmedetomidine.

Conclusion

Dexmedetomidine appears safe and effective as an adjunctive sedative in ESD, reducing restlessness without significant adverse events. The risk of bradycardia is increased, which may reflect reduced physiological stress. Future studies should explore optimal dosing and compare Dexmedetomidine with other sedatives in diverse populations.

Schlagwörter

Stichwörter der Autor:innen

DexmedetomidineESDEndoscopic Submucosal DissectionMeta-AnalysisPrecedexSystematic Review

Autor:innen und Institutionen

  • Department of Internal Medicine, Icahn School of Medicine at Mount Sinai / NYC Health + Hospitals Queens, NY, USA.
  • Faculty of Medicine, October 6 University, Giza, Egypt.
  • University of Maryland Medical Center Midtown Campus, Baltimore, MD, USA.
  • Mayo Clinic Gastroenterology and Hepatology, Rochester, MN, USA.
  • Department of Gastroenterology, University of Missouri, Columbia, MO, USA.
  • Montefiore-Einstein Cerebrovascular Research Lab, Albert Einstein College of Medicine, Bronx, NY, USA.

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Abosheaishaa, H., Abdallfatah, A., Abdelghany, A., Sethi, A., Ismail, A., Mohamed, D., Aboeldahb, M., Abdelhalim, O., Mohamed, I., Azzam, A. Y., Essibayi, M. A., Altschul, D. J., Nassar, M., & Bilal, M. (2025). Dexmedetomidine as an Adjunctive Sedative in Patients Undergoing Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis. ASIDE Gastroenterology. https://doi.org/10.71079/aside.gi.0109257

Vancouver

Abosheaishaa H, Abdallfatah A, Abdelghany A, Sethi A, Ismail A, Mohamed D, et al. Dexmedetomidine as an Adjunctive Sedative in Patients Undergoing Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis. ASIDE Gastroenterology. 2025. doi:10.71079/aside.gi.0109257

BibTeX
@article{Abosheaishaa2025,
  author = {Abosheaishaa, Hazem and Abdallfatah, Abdallfatah and Abdelghany, Abdelmalek and Sethi, Arshia and Ismail, Abdellatif and Mohamed, Doha and Aboeldahb, Moataz and Abdelhalim, Omar and Mohamed, Islam and Azzam, Ahmed Y and Essibayi, Muhammed Amir and Altschul, David J and Nassar, Mahmoud and Bilal, Mohammad},
  title = {Dexmedetomidine as an Adjunctive Sedative in Patients Undergoing Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis},
  journal = {ASIDE Gastroenterology},
  year = {2025},
  doi = {10.71079/aside.gi.0109257}
}
Kostenlos starten →